MINI FUTURE LONG - QUEST DIAGNOSTICS | Real-time Boerse Frankfurt Warrants 08:21:01 2024-05-13 EDT | ||
| 2.26 EUR | -0.44% |
|
| Current month | -2.16% | ||
| 1 month | +32.75% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-13 | 2.26 | -0.44% | 0 |
| 24-05-10 | 2.27 | +4.13% | 0 |
| 24-05-09 | 2.18 | +5.83% | 0 |
| 24-05-08 | 2.06 | -2.83% | 0 |
| 24-05-07 | 2.12 | +4.43% | 0 |
Real-time Boerse Frankfurt Warrants
Last update May 13, 2024 at 08:21 am
More quotesStatic data
| Product type | Knock-Out mit Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | 
BNP Paribas
|
| WKN | PZ0YY8 |
| ISIN | DE000PZ0YY85 |
| Date issued | 2023-11-03 |
| Strike | 114.6 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.17 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.84 € |
|---|---|
| Lowest since issue | 0.95 € |
| Spread | 0.05 € |
| Spread % | 2.17% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
138.4
USD
Average target price
146.7
USD
Spread / Average Target
+6.01%
- Stock Market
- Certificates
- Certificat